SLC6A4 and Fabry disease: Our data demonstrated that, although significant, differences of SLC6A4 methylation status seen in this study are mostly small with large overlap between cases and controls, suggesting the pathogenic role of SLC6A4 methylation status only in a subset of FD patients.